Edgardo G Alicaway, MD
Neurology · Daly City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 42 years
- Graduated 1984
Offices
1 location
Hospitals listed: Ahmc Seton Medical Center · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Alicaway’s office at (650) 756-2597 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A50500 · Current
Licensed to practise in California · since 1992 · expires 2027-05-31 · Cebu Institute of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ahmc Seton Medical CenterDaly City, CAAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Ahmc Seton Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 229 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.49 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.9 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.1 to 4.43) · 361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.62 (0 to 18.38) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.98 (1.71 to 10.25) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 77 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.4 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 48 cases | No different | Jan 2022 – Dec 2024 |
What patients said (257 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$97,228
Medicare paid this office $97,228 for 368 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 193 | $33,897 | $109 |
| New patient visit (60+ min) | 135 | $25,345 | $188 |
| Long return visit (40+ min) | 106 | $19,274 | $153 |
| Short return visit (20+ min) | 94 | $9,132 | $73 |
| New patient visit (45+ min) | 11 | $1,371 | $125 |
See all 7 services
| Return visit (30+ min) | 193 | $33,897 | $109 |
| New patient visit (60+ min) | 135 | $25,345 | $188 |
| Long return visit (40+ min) | 106 | $19,274 | $153 |
| Short return visit (20+ min) | 94 | $9,132 | $73 |
| New patient visit (45+ min) | 11 | $1,371 | $125 |
| Muscle electrical test | 11 | $1,330 | $102 |
| Repositioning exercises of head for treatment of dizziness, each day | 14 | $701 | $39 |
Who their Medicare patients are
368 Original Medicare patients in 2024. Average age 76 · Under 65 9% · 85 and older 20% · Women 61% · Also on Medicaid 39% · Health risk score 1.51. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Diabetes 48% · Coronary heart disease 33% · Dementia 31% · Chronic kidney disease 27% · Stroke 27% · Atrial fibrillation 23% · Depression 21% · Heart failure 18% · Cancer 11% · COPD 11%.
The office billed $147,786, Medicare allowed $138,875 and paid $97,228; for 790 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 368 | 790 | 76 | 1.51 | $147,786 | $97,228 |
| 2023 | 356 | 830 | 76 | 1.57 | $138,141 | $89,293 |
| 2022 | 383 | 956 | 76 | 1.57 | $155,094 | $101,600 |
| 2021 | 389 | 960 | 76 | 1.65 | $153,805 | $104,223 |
| 2020 | 412 | 1,033 | 74 | 1.98 | $154,534 | $103,922 |
| 2019 | 512 | 1,286 | 75 | 1.79 | $194,763 | $127,269 |
| 2018 | 505 | 1,289 | 74 | 1.71 | $196,549 | $126,285 |
| 2017 | 435 | 1,138 | 73 | 1.62 | $182,723 | $119,332 |
| 2016 | 541 | 1,917 | 75 | 1.84 | $264,536 | $175,082 |
| 2015 | 525 | 1,590 | 76 | 2.10 | $225,142 | $156,350 |
| 2014 | 574 | 1,845 | 75 | 2.15 | $251,753 | $171,385 |
| 2013 | 692 | 2,261 | 75 | 1.96 | $317,982 | $215,120 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 167 | $26,401 | $105 |
| New patient visit (60+ min) | 90 | $15,173 | $169 |
| Long return visit (40+ min) | 48 | $9,322 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $8,396 | $94 |
| Short return visit (20+ min) | 85 | $7,588 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $6,658 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $5,934 | $69 |
| New patient visit (45+ min) | 15 | $1,618 | $108 |
| Repositioning exercises of head for treatment of dizziness, each day | 14 | $618 | $41 |
2022: 9 services
| Return visit (30+ min) | 155 | $25,685 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $13,851 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 93 | $13,130 | $90 |
| Long return visit (40+ min) | 70 | $10,774 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $8,418 | $62 |
| New patient visit (60+ min) | 43 | $7,785 | $181 |
| Short return visit (20+ min) | 78 | $6,542 | $67 |
| New patient visit (45+ min) | 43 | $5,471 | $127 |
| Critical care, first 30-74 minutes | 17 | $3,025 | $178 |
2021: 10 services
| Return visit (30+ min) | 187 | $31,459 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $11,026 | $175 |
| New patient visit (45+ min) | 71 | $9,496 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 76 | $9,395 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $8,238 | $64 |
| Long return visit (40+ min) | 56 | $7,995 | $140 |
| New patient visit (60+ min) | 43 | $7,873 | $183 |
| Short return visit (20+ min) | 69 | $6,689 | $74 |
| Muscle electrical test | 13 | $1,515 | $84 |
| Short return visit | 11 | $602 | $55 |
2020: 10 services
| Return visit (30+ min) | 175 | $21,924 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 95 | $17,418 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 80 | $13,770 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 96 | $11,833 | $95 |
| New patient visit (45+ min) | 61 | $8,306 | $136 |
| Long return visit (40+ min) | 57 | $7,336 | $120 |
| Critical care, first 30-74 minutes | 21 | $4,761 | $198 |
| New patient visit (60+ min) | 26 | $4,443 | $171 |
| Short return visit (20+ min) | 53 | $4,112 | $62 |
| New patient visit (60+ min) | 14 | $1,952 | $139 |
2019: 14 services
| Return visit (30+ min) | 203 | $27,609 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 115 | $20,748 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 104 | $14,878 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 120 | $14,475 | $92 |
| New patient visit (45+ min) | 81 | $11,125 | $137 |
| Long return visit (40+ min) | 71 | $8,906 | $110 |
| Critical care, first 30-74 minutes | 29 | $5,826 | $194 |
| Short return visit (20+ min) | 80 | $5,657 | $60 |
| New patient visit (60+ min) | 27 | $4,323 | $160 |
| Nerve test | 12 | $3,226 | $269 |
| New patient visit (60+ min) | 20 | $2,670 | $133 |
| Muscle electrical test | 17 | $1,881 | $90 |
| Return visit (30+ min) | 12 | $1,078 | $67 |
| Long return visit (40+ min) | 11 | $816 | $74 |
2018: 12 services
| Return visit (30+ min) | 240 | $34,738 | $83 |
| New patient visit (45+ min) | 119 | $15,624 | $131 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $14,503 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $12,540 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $11,763 | $63 |
| Long return visit (40+ min) | 73 | $9,555 | $121 |
| Critical care, first 30-74 minutes | 27 | $6,965 | $188 |
| Short return visit (20+ min) | 63 | $4,779 | $62 |
| New patient visit (60+ min) | 26 | $3,668 | $141 |
| New patient visit (60+ min) | 17 | $2,280 | $134 |
| Long return visit (40+ min) | 11 | $1,382 | $99 |
| Muscle electrical test | 11 | $1,262 | $90 |
2017: 15 services
| Return visit (30+ min) | 274 | $43,627 | $90 |
| New patient visit (60+ min) | 83 | $14,988 | $181 |
| New patient visit (45+ min) | 96 | $12,998 | $135 |
| Long return visit (40+ min) | 70 | $8,908 | $117 |
| Nerve test | 22 | $6,196 | $282 |
| Short return visit (20+ min) | 58 | $4,206 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $4,059 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,441 | $93 |
| Muscle electrical test | 27 | $3,431 | $90 |
| New patient visit (30+ min) | 39 | $3,408 | $87 |
| Nerve test | 11 | $2,770 | $252 |
| Extended office or other outpatient service, first hour | 36 | $2,491 | $69 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,840 | $167 |
| Muscle electrical test | 14 | $1,017 | $60 |
| Repositioning exercises of head for treatment of dizziness, each day | 11 | $466 | $36 |
2016: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 206 | $40,287 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 177 | $31,790 | $171 |
| Return visit (30+ min) | 212 | $29,465 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 185 | $25,887 | $88 |
| Critical care, first 30-74 minutes | 58 | $13,318 | $185 |
| New patient visit (45+ min) | 45 | $5,518 | $123 |
| Extended office or other outpatient service, first hour | 56 | $4,805 | $86 |
| New patient visit (30+ min) | 51 | $4,599 | $90 |
| Long return visit (40+ min) | 35 | $4,590 | $124 |
| Short return visit (20+ min) | 41 | $2,669 | $58 |
| New patient visit (60+ min) | 13 | $1,920 | $148 |
| New patient visit (60+ min) | 14 | $1,885 | $135 |
| Return visit (30+ min) | 17 | $1,346 | $67 |
2015: 10 services
| Return visit (30+ min) | 208 | $33,188 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 171 | $28,180 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 141 | $25,879 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 181 | $23,466 | $91 |
| Critical care, first 30-74 minutes | 67 | $14,609 | $192 |
| New patient visit (30+ min) | 64 | $5,893 | $92 |
| Extended office or other outpatient service, first hour | 66 | $5,891 | $89 |
| Long return visit (40+ min) | 42 | $5,203 | $124 |
| New patient visit (45+ min) | 29 | $4,208 | $145 |
| Short return visit (20+ min) | 25 | $1,382 | $51 |
2014: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 233 | $44,206 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 195 | $36,651 | $176 |
| Return visit (30+ min) | 230 | $31,737 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 198 | $22,848 | $90 |
| New patient visit (45+ min) | 53 | $7,077 | $134 |
| Critical care, first 30-74 minutes | 34 | $6,920 | $192 |
| Extended office or other outpatient service, first hour | 48 | $4,284 | $89 |
| New patient visit (30+ min) | 43 | $3,988 | $93 |
| Long return visit (40+ min) | 26 | $2,693 | $104 |
| New patient visit (45+ min) | 17 | $1,968 | $116 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,462 | $122 |
| Short return visit (20+ min) | 11 | $754 | $69 |
2013: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 274 | $52,323 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 254 | $47,215 | $173 |
| Return visit (30+ min) | 254 | $39,105 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 255 | $29,829 | $89 |
| Critical care, first 30-74 minutes | 42 | $8,919 | $190 |
| New patient visit (45+ min) | 51 | $7,682 | $151 |
| New patient visit (60+ min) | 41 | $6,064 | $148 |
| Nerve test | 13 | $3,665 | $282 |
| Long return visit (40+ min) | 27 | $3,543 | $118 |
| New patient visit (30+ min) | 34 | $3,241 | $95 |
| New patient visit (45+ min) | 19 | $2,142 | $113 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,137 | $119 |
| Extended office or other outpatient service, first hour | 20 | $1,750 | $88 |
| Muscle electrical test | 16 | $1,608 | $85 |
| Return visit (30+ min) | 13 | $951 | $68 |
| Short return visit (20+ min) | 12 | $795 | $61 |
Medicaid work
$24,582 in 2024
Medicaid paid $24,582 for 629 billed services this clinician did in 2024, up to 51 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 351 | $12,649 |
| New patient visit (60+ min) | 93 | $5,535 |
| Short return visit (20+ min) | 119 | $3,680 |
| Long return visit (40+ min) | 66 | $2,717 |
| 2024 | 629 | 4 | 51 | $24,582 |
| 2023 | 610 | 4 | 43 | $19,538 |
| 2022 | 543 | 5 | 39 | $16,265 |
| 2021 | 579 | 6 | 45 | $16,961 |
| 2020 | 587 | 6 | 35 | $17,783 |
| 2019 | 896 | 6 | 48 | $23,244 |
| 2018 | 566 | 6 | 50 | $16,557 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 386 | $13,185 |
| Short return visit (20+ min) | 132 | $3,084 |
| New patient visit (60+ min) | 66 | $2,491 |
| Long return visit (40+ min) | 26 | $779 |
2022
| Return visit (30+ min) | 336 | $10,700 |
| Short return visit (20+ min) | 97 | $2,245 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 61 | $1,464 |
| Long return visit (40+ min) | 28 | $1,432 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 21 | $423 |
2021
| Return visit (30+ min) | 432 | $12,852 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 48 | $1,143 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 34 | $1,103 |
| Short return visit (20+ min) | 40 | $784 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $612 |
| New patient visit (60+ min) | 13 | $467 |
2020
| Return visit (30+ min) | 321 | $9,615 |
| Short return visit (20+ min) | 68 | $2,280 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 86 | $2,008 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 72 | $1,979 |
| 1ST HOSP IP/OBS HIGH 75 | 27 | $998 |
| New patient visit (60+ min) | 13 | $902 |
2019
| Return visit (30+ min) | 425 | $10,280 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 219 | $4,923 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 141 | $4,158 |
| 1ST HOSP IP/OBS HIGH 75 | 64 | $2,975 |
| Short return visit (20+ min) | 32 | $518 |
| Long return visit (40+ min) | 15 | $389 |
2018
| Return visit (30+ min) | 468 | $13,624 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 29 | $937 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $851 |
| New patient visit (60+ min) | 12 | $511 |
| Short return visit (20+ min) | 33 | $330 |
| Long return visit (40+ min) | 12 | $304 |
Drugs they prescribed that Part D paid
$784,074
Pharmacies billed $784,074 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (33 of 4,351) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%.
4,201 generic and 100 brand-name prescriptions · $784,074 in drug cost · 181 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Nuplazid | Parkinson's psychosis | 12 | $60,011 | $5,001 |
| Aimovig | Migraine | 33 | $51,373 | $1,557 |
| Lacosamide | None | 229 | $41,345 | $181 |
| Memantine | None | 498 | $28,029 | $56 |
| Levetiracetam | None | 332 | $21,692 | $65 |
See all 51 drugs
| Nuplazid | Parkinson's psychosis | 12 | $60,011 | $5,001 |
| Aimovig | Migraine | 33 | $51,373 | $1,557 |
| Lacosamide | None | 229 | $41,345 | $181 |
| Memantine | None | 498 | $28,029 | $56 |
| Levetiracetam | None | 332 | $21,692 | $65 |
| Carbidopa | None | 20 | $16,427 | $821 |
| Divalproex | None | 239 | $16,205 | $68 |
| Carbidopa-Levodopa | None | 328 | $14,593 | $44 |
| Lamotrigine | None | 254 | $13,891 | $55 |
| Gabapentin | None | 365 | $11,809 | $32 |
| Entacapone | None | 42 | $11,398 | $271 |
| Donepezil | None | 256 | $9,422 | $37 |
| Pregabalin | None | 119 | $8,678 | $73 |
| Quetiapine | None | 97 | $5,327 | $55 |
| Rasagiline Mesylate | None | 12 | $5,010 | $418 |
| Oxcarbazepine | None | 57 | $4,096 | $72 |
| Carbamazepine | None | 48 | $4,008 | $83 |
| Duloxetine | None | 48 | $3,636 | $76 |
| Carbamazepine Er | None | 19 | $3,587 | $189 |
| Phenobarbital | None | 50 | $3,047 | $61 |
| Amantadine | None | 38 | $2,201 | $58 |
| Carbidopa-Levodopa Er | None | 39 | $2,097 | $54 |
| Primidone | None | 35 | $2,016 | $58 |
| Divalproex Sodium Er | None | 42 | $1,977 | $47 |
| Zonisamide | None | 49 | $1,955 | $40 |
| Nortriptyline | None | 78 | $1,933 | $25 |
| Valproic Acid | None | 45 | $1,886 | $42 |
| Risperidone | None | 89 | $1,743 | $20 |
| Propranolol Hcl Er | None | 28 | $1,668 | $60 |
| Mirtazapine | None | 68 | $1,662 | $24 |
| Phenytoin Sodium Extended | None | 49 | $1,565 | $32 |
| Atorvastatin | None | 68 | $1,485 | $22 |
| Topiramate | None | 47 | $1,288 | $27 |
| Pramipexole Dihydrochloride | None | 29 | $1,168 | $40 |
| Baclofen | None | 20 | $961 | $48 |
| Clopidogrel | None | 44 | $961 | $22 |
| Venlafaxine Hcl Er | None | 17 | $924 | $54 |
| Citalopram Hbr | None | 69 | $761 | $11 |
| Phenytoin | None | 24 | $605 | $25 |
| Amitriptyline | None | 24 | $519 | $22 |
| Glycopyrrolate | None | 12 | $269 | $22 |
| Clonazepam | None | 41 | $263 | $6 |
| Trazodone | None | 43 | $263 | $6 |
| Benztropine Mesylate | None | 12 | $253 | $21 |
| Promethazine | None | 12 | $218 | $18 |
| Hydrocodone-Acetaminophen | None | 12 | $151 | $13 |
| Rizatriptan | None | 13 | $149 | $11 |
| Lorazepam | None | 22 | $118 | $5 |
| Trihexyphenidyl | None | 16 | $71 | $4 |
| Tramadol | None | 17 | $38 | $2 |
| Alprazolam | None | 12 | $29 | $2 |
Year by year
| 2024 | 4,351 | 617 | 1% (33) | 2% | $784,074 |
| 2023 | 3,965 | 526 | 1% (29) | 3% | $874,814 |
| 2022 | 3,828 | 492 | 1% (43) | 6% | $676,854 |
| 2021 | 3,904 | 495 | 1% (47) | 10% | $667,065 |
| 2020 | 3,868 | 472 | 2% (65) | 12% | $708,161 |
| 2019 | 3,556 | 467 | 2% (59) | 12% | $597,394 |
| 2018 | 4,031 | 470 | 2% (87) | 11% | $599,567 |
| 2017 | 4,304 | 483 | 3% (129) | 12% | $491,909 |
| 2016 | 3,996 | 380 | 3% (137) | 15% | $560,934 |
| 2015 | 4,112 | 388 | 4% (169) | 19% | $647,937 |
| 2014 | 3,940 | 355 | 4% (153) | 21% | $562,958 |
| 2013 | 3,837 | 342 | 4% (167) | 21% | $524,635 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 51 drugs
| Gammagard Liquid | Immune globulin | 18 | $453,103 | $25,172 |
| Lacosamide | None | 242 | $69,270 | $286 |
| Aimovig | Migraine | 30 | $50,639 | $1,688 |
| Memantine | None | 365 | $26,282 | $72 |
| Levetiracetam | None | 282 | $19,474 | $69 |
| Entacapone | None | 53 | $17,461 | $329 |
| Carbidopa-Levodopa | None | 317 | $17,259 | $54 |
| Divalproex | None | 279 | $15,170 | $54 |
| Gabapentin | None | 305 | $12,279 | $40 |
| Lamotrigine | None | 246 | $8,994 | $37 |
| Donepezil | None | 251 | $8,424 | $34 |
| Pregabalin | None | 98 | $6,292 | $64 |
| Phenobarbital | None | 84 | $4,801 | $57 |
| Duloxetine | None | 61 | $4,400 | $72 |
| Quetiapine | None | 95 | $4,294 | $45 |
| Pramipexole Dihydrochloride | None | 35 | $4,255 | $122 |
| Carbamazepine Er | None | 17 | $4,191 | $247 |
| Carbamazepine | None | 41 | $3,684 | $90 |
| Carbidopa | None | 11 | $3,624 | $329 |
| Primidone | None | 38 | $3,148 | $83 |
| Memantine Hcl Er | None | 16 | $2,993 | $187 |
| Mirtazapine | None | 88 | $2,860 | $33 |
| Rivastigmine | None | 12 | $2,617 | $218 |
| Phenytoin Sodium Extended | None | 54 | $2,417 | $45 |
| Valproic Acid | None | 50 | $2,252 | $45 |
| Oxcarbazepine | None | 38 | $2,150 | $57 |
| Divalproex Sodium Er | None | 25 | $1,780 | $71 |
| Amantadine | None | 20 | $1,738 | $87 |
| Propranolol Hcl Er | None | 23 | $1,642 | $71 |
| Carbidopa-Levodopa Er | None | 25 | $1,617 | $65 |
| Topiramate | None | 48 | $1,588 | $33 |
| Citalopram Hbr | None | 90 | $1,485 | $16 |
| Zonisamide | None | 36 | $1,346 | $37 |
| Nortriptyline | None | 54 | $1,257 | $23 |
| Risperidone | None | 65 | $1,255 | $19 |
| Atorvastatin | None | 36 | $1,231 | $34 |
| Ropinirole | None | 11 | $1,150 | $105 |
| Olanzapine | None | 12 | $804 | $67 |
| Clonazepam | None | 54 | $726 | $13 |
| Venlafaxine Hcl Er | None | 14 | $693 | $50 |
| Clopidogrel | None | 27 | $623 | $23 |
| Phenytoin | None | 22 | $563 | $26 |
| Amitriptyline | None | 14 | $456 | $33 |
| Baclofen | None | 19 | $424 | $22 |
| Benztropine Mesylate | None | 13 | $275 | $21 |
| Glycopyrrolate | None | 13 | $243 | $19 |
| Donepezil Hcl Odt | None | 12 | $239 | $20 |
| Lorazepam | None | 14 | $149 | $11 |
| Trihexyphenidyl | None | 16 | $82 | $5 |
| Tramadol | None | 16 | $78 | $5 |
| Alprazolam | None | 12 | $32 | $3 |
2022: 52 drugs
| Gammagard Liquid | Immune globulin | 11 | $232,363 | $21,124 |
| Vimpat | None | 89 | $94,016 | $1,056 |
| Lacosamide | None | 141 | $41,121 | $292 |
| Aimovig | Migraine | 14 | $24,200 | $1,729 |
| Memantine | None | 280 | $22,026 | $79 |
| Divalproex | None | 232 | $19,501 | $84 |
| Levetiracetam | None | 293 | $18,863 | $64 |
| Neupro | None | 17 | $16,191 | $952 |
| Entacapone | None | 53 | $15,663 | $296 |
| Gabapentin | None | 314 | $13,189 | $42 |
| Carbidopa-Levodopa | None | 256 | $12,831 | $50 |
| Carbidopa | None | 15 | $10,432 | $695 |
| Lamotrigine | None | 239 | $7,681 | $32 |
| Donepezil | None | 270 | $7,322 | $27 |
| Pregabalin | None | 86 | $6,081 | $71 |
| Phenobarbital | None | 93 | $4,877 | $52 |
| Duloxetine | None | 48 | $4,737 | $99 |
| Memantine Hcl Er | None | 22 | $4,411 | $200 |
| Carbamazepine Er | None | 23 | $4,103 | $178 |
| Mirtazapine | None | 113 | $3,975 | $35 |
| Phenytoin Sodium Extended | None | 88 | $3,729 | $42 |
| Carbamazepine | None | 35 | $3,266 | $93 |
| Quetiapine | None | 65 | $2,276 | $35 |
| Carbidopa-Levodopa Er | None | 34 | $2,215 | $65 |
| Primidone | None | 27 | $2,207 | $82 |
| Pramipexole Dihydrochloride | None | 38 | $1,695 | $45 |
| Oxcarbazepine | None | 30 | $1,564 | $52 |
| Divalproex Sodium Er | None | 22 | $1,477 | $67 |
| Clopidogrel | None | 31 | $1,415 | $46 |
| Amantadine | None | 15 | $1,316 | $88 |
| Citalopram Hbr | None | 77 | $1,298 | $17 |
| Risperidone | None | 71 | $1,185 | $17 |
| Valproic Acid | None | 46 | $1,139 | $25 |
| Nortriptyline | None | 43 | $1,116 | $26 |
| Amitriptyline | None | 28 | $999 | $36 |
| Atorvastatin | None | 39 | $812 | $21 |
| Ropinirole | None | 16 | $810 | $51 |
| Baclofen | None | 18 | $739 | $41 |
| Topiramate | None | 36 | $731 | $20 |
| Zonisamide | None | 21 | $707 | $34 |
| Clonazepam | None | 58 | $598 | $10 |
| Phenytoin | None | 23 | $519 | $23 |
| Benztropine Mesylate | None | 17 | $350 | $21 |
| Glycopyrrolate | None | 14 | $349 | $25 |
| Donepezil Hcl Odt | None | 12 | $209 | $17 |
| Hydrocodone-Acetaminophen | None | 11 | $162 | $15 |
| Methylprednisolone Sodium Succ | None | 11 | $143 | $13 |
| Trihexyphenidyl | None | 16 | $87 | $5 |
| Sodium Chloride | None | 11 | $69 | $6 |
| Tramadol | None | 19 | $57 | $3 |
| Lorazepam | None | 12 | $47 | $4 |
| Alprazolam | None | 12 | $35 | $3 |
2021: 53 drugs
| Vimpat | 230 | $242,123 | $1,053 |
| Levetiracetam | 320 | $21,822 | $68 |
| Carbidopa | 29 | $17,600 | $607 |
| Entacapone | 63 | $17,245 | $274 |
| Memantine | 232 | $16,427 | $71 |
| Gabapentin | 374 | $16,353 | $44 |
| Carbidopa-Levodopa | 264 | $13,785 | $52 |
| Fycompa | 18 | $13,566 | $754 |
| Exelon | 11 | $12,785 | $1,162 |
| Neupro | 18 | $12,636 | $702 |
| Divalproex | 202 | $12,573 | $62 |
| Lamotrigine | 238 | $9,196 | $39 |
| Eliquis | 18 | $8,805 | $489 |
| Donepezil | 307 | $6,935 | $23 |
| Pregabalin | 88 | $6,005 | $68 |
| Phenobarbital | 92 | $5,177 | $56 |
| Memantine Hcl Er | 24 | $4,220 | $176 |
| Carbamazepine | 43 | $4,079 | $95 |
| Carbamazepine Er | 29 | $3,698 | $128 |
| Mirtazapine | 93 | $3,109 | $33 |
| Phenytoin Sodium Extended | 75 | $2,876 | $38 |
| Amantadine | 26 | $2,534 | $97 |
| Pramipexole Dihydrochloride | 66 | $2,421 | $37 |
| Duloxetine | 68 | $2,394 | $35 |
| Quetiapine | 71 | $2,108 | $30 |
| Carbidopa-Levodopa Er | 28 | $2,015 | $72 |
| Oxcarbazepine | 28 | $1,764 | $63 |
| Divalproex Sodium Er | 28 | $1,679 | $60 |
| Clopidogrel | 38 | $1,641 | $43 |
| Valproic Acid | 36 | $1,542 | $43 |
| Baclofen | 36 | $1,248 | $35 |
| Ropinirole | 30 | $1,218 | $41 |
| Fentanyl | 11 | $1,215 | $110 |
| Nortriptyline | 44 | $1,125 | $26 |
| Primidone | 16 | $974 | $61 |
| Clonazepam | 73 | $721 | $10 |
| Butalbital-Acetaminophen-Caffe | 14 | $690 | $49 |
| Phenytoin | 26 | $567 | $22 |
| Zonisamide | 12 | $561 | $47 |
| Topiramate | 30 | $514 | $17 |
| Citalopram Hbr | 41 | $513 | $13 |
| Escitalopram | 23 | $508 | $22 |
| Atorvastatin | 25 | $481 | $19 |
| Trazodone | 13 | $356 | $27 |
| Risperidone | 25 | $355 | $14 |
| Olanzapine | 17 | $300 | $18 |
| Amitriptyline | 13 | $288 | $22 |
| Benztropine Mesylate | 12 | $223 | $19 |
| Lorazepam | 13 | $158 | $12 |
| Glycopyrrolate | 12 | $134 | $11 |
| Trihexyphenidyl | 18 | $98 | $5 |
| Tramadol | 20 | $62 | $3 |
| Alprazolam | 12 | $33 | $3 |
2020: 56 drugs
| Vimpat | 212 | $209,569 | $989 |
| Fycompa | 36 | $49,371 | $1,371 |
| Banzel | 12 | $36,485 | $3,040 |
| Neupro | 25 | $23,730 | $949 |
| Entacapone | 69 | $19,681 | $285 |
| Carbidopa | 22 | $17,291 | $786 |
| Levetiracetam | 361 | $16,822 | $47 |
| Memantine | 196 | $15,050 | $77 |
| Carbidopa-Levodopa | 248 | $13,888 | $56 |
| Gabapentin | 312 | $12,910 | $41 |
| Trokendi Xr | 12 | $10,235 | $853 |
| Rivastigmine | 27 | $9,248 | $343 |
| Divalproex | 163 | $6,963 | $43 |
| Eliquis | 11 | $6,487 | $590 |
| Pregabalin | 93 | $6,346 | $68 |
| Memantine Hcl Er | 31 | $5,999 | $194 |
| Lamotrigine | 285 | $5,194 | $18 |
| Donepezil | 259 | $4,807 | $19 |
| Phenobarbital | 86 | $4,698 | $55 |
| Venlafaxine Hcl Er | 41 | $4,132 | $101 |
| Carbamazepine Er | 20 | $4,101 | $205 |
| Carbamazepine | 53 | $3,644 | $69 |
| Amantadine | 26 | $3,016 | $116 |
| Oxcarbazepine | 51 | $2,891 | $57 |
| Phenytoin Sodium Extended | 89 | $2,883 | $32 |
| Pramipexole Dihydrochloride | 76 | $2,513 | $33 |
| Carbidopa-Levodopa Er | 36 | $2,293 | $64 |
| Mirtazapine | 60 | $2,122 | $35 |
| Divalproex Sodium Er | 46 | $1,766 | $38 |
| Duloxetine | 37 | $1,440 | $39 |
| Quetiapine | 51 | $1,344 | $26 |
| Nortriptyline | 47 | $1,302 | $28 |
| Fentanyl | 12 | $1,241 | $103 |
| Clopidogrel | 41 | $1,115 | $27 |
| Baclofen | 17 | $1,071 | $63 |
| Primidone | 23 | $1,017 | $44 |
| Atorvastatin | 30 | $869 | $29 |
| Phenytoin | 46 | $844 | $18 |
| Ropinirole | 13 | $818 | $63 |
| Butalbital-Acetaminophen-Caffe | 14 | $703 | $50 |
| Topiramate | 40 | $658 | $16 |
| Hydrocodone-Acetaminophen | 16 | $618 | $39 |
| Citalopram Hbr | 41 | $596 | $15 |
| Valproic Acid | 15 | $506 | $34 |
| Clonazepam | 59 | $497 | $8 |
| Olanzapine | 18 | $453 | $25 |
| Amitriptyline | 18 | $426 | $24 |
| Fluoxetine | 18 | $413 | $23 |
| Lorazepam | 23 | $240 | $10 |
| Escitalopram | 14 | $239 | $17 |
| Tizanidine | 13 | $220 | $17 |
| Trihexyphenidyl | 26 | $208 | $8 |
| Tramadol | 34 | $181 | $5 |
| Benztropine Mesylate | 12 | $113 | $9 |
| Meloxicam | 14 | $107 | $8 |
| Alprazolam | 12 | $33 | $3 |
2019: 52 drugs
| Vimpat | 128 | $133,821 | $1,045 |
| Tecfidera | 12 | $96,032 | $8,003 |
| Fycompa | 38 | $47,973 | $1,262 |
| Banzel | 11 | $31,904 | $2,900 |
| Lyrica | 28 | $21,916 | $783 |
| Entacapone | 73 | $21,309 | $292 |
| Neupro | 28 | $19,430 | $694 |
| Rivastigmine | 47 | $18,468 | $393 |
| Carbidopa | 21 | $16,489 | $785 |
| Levetiracetam | 354 | $12,991 | $37 |
| Memantine | 208 | $12,597 | $61 |
| Carbidopa-Levodopa | 242 | $11,300 | $47 |
| Gabapentin | 349 | $10,771 | $31 |
| Memantine Hcl Er | 33 | $8,045 | $244 |
| Divalproex | 170 | $7,649 | $45 |
| Donepezil | 273 | $5,027 | $18 |
| Lamotrigine | 219 | $4,462 | $20 |
| Carbamazepine | 51 | $3,721 | $73 |
| Carbamazepine Er | 18 | $3,611 | $201 |
| Phenobarbital | 57 | $3,285 | $58 |
| Amantadine | 24 | $3,154 | $131 |
| Carbidopa-Levodopa Er | 57 | $2,988 | $52 |
| Oxcarbazepine | 50 | $2,813 | $56 |
| Divalproex Sodium Er | 38 | $2,505 | $66 |
| Phenytoin Sodium Extended | 76 | $2,463 | $32 |
| Pramipexole Dihydrochloride | 75 | $2,269 | $30 |
| Duloxetine | 27 | $2,193 | $81 |
| Pregabalin | 13 | $1,874 | $144 |
| Baclofen | 19 | $1,655 | $87 |
| Clopidogrel | 56 | $1,633 | $29 |
| Quetiapine | 40 | $1,379 | $34 |
| Fentanyl | 12 | $1,362 | $114 |
| Mirtazapine | 62 | $1,338 | $22 |
| Phenytoin | 32 | $877 | $27 |
| Atorvastatin | 29 | $804 | $28 |
| Fluoxetine | 20 | $791 | $40 |
| Primidone | 22 | $647 | $29 |
| Nortriptyline | 40 | $627 | $16 |
| Topiramate | 29 | $502 | $17 |
| Citalopram Hbr | 36 | $449 | $12 |
| Valproic Acid | 14 | $395 | $28 |
| Hydrocodone-Acetaminophen | 14 | $392 | $28 |
| Olanzapine | 15 | $383 | $26 |
| Clonazepam | 45 | $312 | $7 |
| Trihexyphenidyl | 30 | $285 | $10 |
| Tramadol | 31 | $275 | $9 |
| Tizanidine | 13 | $262 | $20 |
| Risperidone | 18 | $242 | $13 |
| Lorazepam | 25 | $198 | $8 |
| Meloxicam | 11 | $133 | $12 |
| Trazodone | 14 | $103 | $7 |
| Alprazolam | 12 | $35 | $3 |
2018: 57 drugs
| Tecfidera | 12 | $90,596 | $7,550 |
| Vimpat | 94 | $89,577 | $953 |
| Lyrica | 61 | $39,605 | $649 |
| Banzel | 11 | $29,894 | $2,718 |
| Carbidopa | 40 | $26,122 | $653 |
| Memantine | 221 | $24,434 | $111 |
| Entacapone | 87 | $23,543 | $271 |
| Levetiracetam | 333 | $20,943 | $63 |
| Neupro | 29 | $20,162 | $695 |
| Namenda Xr | 30 | $18,208 | $607 |
| Donepezil | 322 | $17,651 | $55 |
| Rivastigmine | 49 | $13,692 | $279 |
| Carbidopa-Levodopa | 330 | $13,184 | $40 |
| Lamotrigine | 276 | $11,429 | $41 |
| Gabapentin | 403 | $11,370 | $28 |
| Fycompa | 11 | $9,413 | $856 |
| Phenobarbital | 69 | $5,563 | $81 |
| Carbamazepine | 56 | $4,692 | $84 |
| Pramipexole Dihydrochloride | 91 | $4,075 | $45 |
| Memantine Hcl Er | 23 | $4,030 | $175 |
| Carbamazepine Er | 24 | $3,942 | $164 |
| Oxcarbazepine | 56 | $3,430 | $61 |
| Carbidopa-Levodopa Er | 83 | $3,364 | $41 |
| Divalproex Sodium Er | 59 | $3,317 | $56 |
| Divalproex | 127 | $3,023 | $24 |
| Quetiapine | 44 | $2,914 | $66 |
| Phenytoin Sodium Extended | 69 | $2,784 | $40 |
| Amantadine | 30 | $2,729 | $91 |
| Clopidogrel | 68 | $2,315 | $34 |
| Topiramate | 47 | $2,230 | $47 |
| Baclofen | 15 | $1,859 | $124 |
| Duloxetine | 20 | $1,829 | $91 |
| Propranolol Hcl Er | 14 | $1,429 | $102 |
| Atorvastatin | 44 | $1,405 | $32 |
| Fluoxetine | 19 | $1,357 | $71 |
| Valproic Acid | 35 | $1,181 | $34 |
| Mirtazapine | 49 | $1,149 | $23 |
| Pyridostigmine | 14 | $1,114 | $80 |
| Fentanyl | 16 | $1,108 | $69 |
| Hydrocodone-Acetaminophen | 32 | $1,057 | $33 |
| Phenytoin | 20 | $825 | $41 |
| Nortriptyline | 46 | $799 | $17 |
| Primidone | 32 | $695 | $22 |
| Sumatriptan | 15 | $586 | $39 |
| Tramadol | 35 | $522 | $15 |
| Risperidone | 12 | $508 | $42 |
| Clonazepam | 53 | $375 | $7 |
| Sertraline | 13 | $300 | $23 |
| Olanzapine | 33 | $288 | $9 |
| Citalopram Hbr | 19 | $269 | $14 |
| Trihexyphenidyl | 53 | $269 | $5 |
| Escitalopram | 13 | $268 | $21 |
| Prednisone | 20 | $220 | $11 |
| Lorazepam | 33 | $205 | $6 |
| Trazodone | 21 | $184 | $9 |
| Verapamil Er | 14 | $81 | $6 |
| Alprazolam | 11 | $54 | $5 |
2017: 54 drugs
| Vimpat | 78 | $70,452 | $903 |
| Namenda Xr | 108 | $48,496 | $449 |
| Lyrica | 87 | $44,290 | $509 |
| Rivastigmine | 73 | $20,903 | $286 |
| Levetiracetam | 358 | $19,500 | $54 |
| Exelon | 32 | $19,106 | $597 |
| Carbidopa | 28 | $18,190 | $650 |
| Neupro | 24 | $16,373 | $682 |
| Donepezil | 420 | $14,742 | $35 |
| Memantine | 191 | $14,458 | $76 |
| Entacapone | 59 | $12,486 | $212 |
| Carbidopa-Levodopa | 340 | $12,478 | $37 |
| Lamotrigine | 256 | $10,223 | $40 |
| Gabapentin | 388 | $9,702 | $25 |
| Phenobarbital | 77 | $6,406 | $83 |
| Carbamazepine | 62 | $4,474 | $72 |
| Pramipexole Dihydrochloride | 126 | $4,305 | $34 |
| Carbamazepine Er | 28 | $3,844 | $137 |
| Carbidopa-Levodopa Er | 105 | $3,661 | $35 |
| Oxcarbazepine | 52 | $3,092 | $59 |
| Topiramate | 64 | $2,930 | $46 |
| Duloxetine | 32 | $2,896 | $90 |
| Phenytoin Sodium Extended | 80 | $2,878 | $36 |
| Clopidogrel | 87 | $2,409 | $28 |
| Dilantin | 12 | $2,401 | $200 |
| Divalproex Sodium Er | 31 | $2,243 | $72 |
| Quetiapine | 40 | $2,224 | $56 |
| Fentanyl | 25 | $1,830 | $73 |
| Fluoxetine | 25 | $1,683 | $67 |
| Baclofen | 21 | $1,664 | $79 |
| Propranolol Hcl Er | 18 | $1,453 | $81 |
| Hydrocodone-Acetaminophen | 36 | $1,244 | $35 |
| Mirtazapine | 63 | $1,109 | $18 |
| Nortriptyline | 64 | $998 | $16 |
| Divalproex | 60 | $942 | $16 |
| Valproic Acid | 20 | $909 | $45 |
| Primidone | 50 | $856 | $17 |
| Olanzapine | 23 | $797 | $35 |
| Atorvastatin | 28 | $718 | $26 |
| Sumatriptan | 20 | $622 | $31 |
| Tramadol | 56 | $588 | $11 |
| Trihexyphenidyl | 76 | $533 | $7 |
| Zonisamide | 18 | $464 | $26 |
| Meloxicam | 22 | $454 | $21 |
| Clonazepam | 69 | $427 | $6 |
| Citalopram Hbr | 25 | $357 | $14 |
| Venlafaxine Hcl Er | 13 | $317 | $24 |
| Lorazepam | 34 | $218 | $6 |
| Sertraline | 13 | $217 | $17 |
| Trazodone | 32 | $164 | $5 |
| Diazepam | 12 | $129 | $11 |
| Benztropine Mesylate | 15 | $117 | $8 |
| Alprazolam | 15 | $104 | $7 |
| Prednisone | 21 | $95 | $5 |
2016: 56 drugs
| Copaxone | 21 | $128,554 | $6,122 |
| Namenda Xr | 173 | $72,081 | $417 |
| Lyrica | 83 | $40,728 | $491 |
| Exelon | 61 | $32,473 | $532 |
| Vimpat | 53 | $32,125 | $606 |
| Neupro | 35 | $26,523 | $758 |
| Rivastigmine | 52 | $16,736 | $322 |
| Azilect | 25 | $16,221 | $649 |
| Levetiracetam | 343 | $13,898 | $41 |
| Carbidopa | 27 | $12,255 | $454 |
| Carbidopa-Levodopa | 323 | $10,426 | $32 |
| Entacapone | 40 | $10,326 | $258 |
| Carbamazepine | 56 | $7,431 | $133 |
| Gabapentin | 248 | $7,138 | $29 |
| Memantine | 77 | $5,397 | $70 |
| Phenytoin Sodium Extended | 131 | $5,370 | $41 |
| Phenobarbital | 74 | $4,887 | $66 |
| Carbidopa-Levodopa Er | 138 | $4,881 | $35 |
| Carbamazepine Er | 39 | $4,803 | $123 |
| Duloxetine | 48 | $3,958 | $82 |
| Donepezil | 377 | $3,182 | $8 |
| Lamotrigine | 192 | $3,138 | $16 |
| Sumatriptan | 17 | $3,092 | $182 |
| Oxcarbazepine | 67 | $3,080 | $46 |
| Pramipexole Dihydrochloride | 113 | $2,994 | $26 |
| Hydrocodone-Acetaminophen | 36 | $2,016 | $56 |
| Dilantin | 12 | $2,005 | $167 |
| Fluoxetine | 39 | $1,892 | $49 |
| Fentanyl | 11 | $1,875 | $170 |
| Divalproex Sodium Er | 15 | $1,804 | $120 |
| Divalproex | 59 | $1,370 | $23 |
| Oxycodone | 14 | $1,040 | $74 |
| Quetiapine | 62 | $969 | $16 |
| Clopidogrel | 80 | $906 | $11 |
| Primidone | 51 | $902 | $18 |
| Nortriptyline | 53 | $778 | $15 |
| Baclofen | 20 | $761 | $38 |
| Valproic Acid | 16 | $746 | $47 |
| Zonisamide | 26 | $742 | $29 |
| Clonazepam | 67 | $742 | $11 |
| Topiramate | 58 | $717 | $12 |
| Trihexyphenidyl | 81 | $641 | $8 |
| Olanzapine | 30 | $554 | $18 |
| Mirtazapine | 31 | $510 | $16 |
| Venlafaxine Hcl Er | 19 | $366 | $19 |
| Tramadol | 58 | $352 | $6 |
| Ropinirole | 14 | $278 | $20 |
| Meclizine | 16 | $252 | $16 |
| Lorazepam | 28 | $252 | $9 |
| Hydromorphone | 14 | $247 | $18 |
| Pravastatin | 14 | $225 | $16 |
| Prednisone | 24 | $199 | $8 |
| Atorvastatin | 24 | $168 | $7 |
| Alprazolam | 14 | $95 | $7 |
| Trazodone | 17 | $73 | $4 |
| Paroxetine | 11 | $64 | $6 |
2015: 55 drugs
| Copaxone | 21 | $127,941 | $6,092 |
| Namenda Xr | 193 | $67,414 | $349 |
| Exelon | 120 | $57,962 | $483 |
| Lyrica | 109 | $48,883 | $448 |
| Vimpat | 44 | $33,248 | $756 |
| Namenda | 82 | $28,786 | $351 |
| Neupro | 30 | $20,885 | $696 |
| Entacapone | 58 | $18,152 | $313 |
| Levetiracetam | 372 | $17,164 | $46 |
| Azilect | 24 | $12,927 | $539 |
| Carbidopa-Levodopa | 305 | $11,658 | $38 |
| Gabapentin | 271 | $8,728 | $32 |
| Phenytoin Sodium Extended | 152 | $5,803 | $38 |
| Rivastigmine | 11 | $4,884 | $444 |
| Pramipexole Dihydrochloride | 117 | $4,856 | $42 |
| Carbidopa-Levodopa Er | 107 | $4,462 | $42 |
| Memantine | 19 | $4,313 | $227 |
| Duloxetine | 45 | $4,197 | $93 |
| Carbamazepine | 46 | $4,115 | $89 |
| Donepezil | 296 | $3,283 | $11 |
| Fentanyl | 19 | $3,126 | $165 |
| Divalproex Sodium Er | 18 | $2,628 | $146 |
| Lamotrigine | 182 | $2,596 | $14 |
| Divalproex | 67 | $2,475 | $37 |
| Phenobarbital | 54 | $2,464 | $46 |
| Oxcarbazepine | 71 | $2,344 | $33 |
| Carbamazepine Er | 29 | $2,326 | $80 |
| Propranolol Hcl Er | 14 | $2,194 | $157 |
| Hydrocodone-Acetaminophen | 50 | $1,884 | $38 |
| Dilantin | 12 | $1,591 | $133 |
| Clopidogrel | 84 | $1,242 | $15 |
| Primidone | 59 | $1,151 | $20 |
| Quetiapine | 47 | $1,044 | $22 |
| Topiramate | 91 | $946 | $10 |
| Oxycodone | 13 | $859 | $66 |
| Trihexyphenidyl | 103 | $799 | $8 |
| Fluoxetine | 37 | $745 | $20 |
| Nortriptyline | 49 | $740 | $15 |
| Ropinirole | 27 | $722 | $27 |
| Baclofen | 27 | $670 | $25 |
| Olanzapine | 50 | $641 | $13 |
| Valproic Acid | 25 | $490 | $20 |
| Clonazepam | 72 | $439 | $6 |
| Venlafaxine Hcl Er | 20 | $395 | $20 |
| Sumatriptan | 19 | $377 | $20 |
| Amitriptyline | 13 | $340 | $26 |
| Tramadol | 62 | $331 | $5 |
| Lorazepam | 61 | $321 | $5 |
| Prednisone | 23 | $270 | $12 |
| Hydromorphone | 16 | $248 | $15 |
| Verapamil Er | 16 | $238 | $15 |
| Meclizine | 19 | $233 | $12 |
| Trazodone | 19 | $156 | $8 |
| Mirtazapine | 11 | $102 | $9 |
| Alprazolam | 12 | $61 | $5 |
2014: 51 drugs
| Exelon | 216 | $76,357 | $354 |
| Namenda | 189 | $62,953 | $333 |
| Copaxone | 12 | $61,404 | $5,117 |
| Lyrica | 111 | $40,923 | $369 |
| Namenda Xr | 95 | $29,111 | $306 |
| Entacapone | 73 | $23,327 | $320 |
| Vimpat | 30 | $21,549 | $718 |
| Levetiracetam | 339 | $15,400 | $45 |
| Carbidopa-Levodopa | 303 | $13,958 | $46 |
| Neupro | 19 | $12,653 | $666 |
| Azilect | 23 | $11,367 | $494 |
| Duloxetine | 41 | $9,973 | $243 |
| Gabapentin | 247 | $7,622 | $31 |
| Pramipexole Dihydrochloride | 131 | $5,764 | $44 |
| Donepezil | 245 | $4,677 | $19 |
| Clopidogrel | 111 | $4,662 | $42 |
| Phenytoin Sodium Extended | 153 | $4,206 | $27 |
| Carbidopa-Levodopa Er | 111 | $3,856 | $35 |
| Lamotrigine | 212 | $3,734 | $18 |
| Hydrocodone-Acetaminophen | 72 | $3,484 | $48 |
| Carbamazepine | 76 | $3,116 | $41 |
| Divalproex | 74 | $2,981 | $40 |
| Sumatriptan | 17 | $2,718 | $160 |
| Fentanyl | 16 | $2,092 | $131 |
| Quetiapine | 46 | $2,058 | $45 |
| Propranolol Hcl Er | 21 | $2,038 | $97 |
| Oxcarbazepine | 49 | $1,946 | $40 |
| Divalproex Sodium Er | 15 | $1,917 | $128 |
| Phenobarbital | 44 | $1,802 | $41 |
| Dilantin | 13 | $1,542 | $119 |
| Carbamazepine Er | 12 | $1,314 | $109 |
| Topiramate | 76 | $1,274 | $17 |
| Amantadine | 13 | $1,213 | $93 |
| Primidone | 57 | $970 | $17 |
| Olanzapine | 42 | $675 | $16 |
| Risperidone | 11 | $551 | $50 |
| Nortriptyline | 55 | $509 | $9 |
| Ropinirole | 13 | $495 | $38 |
| Trihexyphenidyl | 79 | $467 | $6 |
| Valproic Acid | 15 | $464 | $31 |
| Baclofen | 32 | $406 | $13 |
| Mirtazapine | 24 | $342 | $14 |
| Tramadol | 43 | $332 | $8 |
| Fluoxetine | 28 | $287 | $10 |
| Clonazepam | 46 | $221 | $5 |
| Lorazepam | 32 | $163 | $5 |
| Prednisone | 26 | $159 | $6 |
| Meloxicam | 12 | $62 | $5 |
| Alprazolam | 12 | $60 | $5 |
| Trazodone | 16 | $60 | $4 |
| Zolpidem | 11 | $28 | $3 |
2013: 48 drugs
| Avonex | 25 | $104,962 | $4,198 |
| Namenda | 259 | $72,769 | $281 |
| Copaxone | 14 | $63,796 | $4,557 |
| Exelon | 144 | $44,452 | $309 |
| Lyrica | 124 | $38,163 | $308 |
| Entacapone | 42 | $18,223 | $434 |
| Levetiracetam | 325 | $17,188 | $53 |
| Vimpat | 28 | $17,164 | $613 |
| Cymbalta | 48 | $16,681 | $348 |
| Gabapentin | 315 | $13,224 | $42 |
| Carbidopa-Levodopa | 290 | $12,927 | $45 |
| Comtan | 25 | $11,669 | $467 |
| Pramipexole Dihydrochloride | 159 | $8,071 | $51 |
| Lamotrigine | 234 | $5,524 | $24 |
| Azilect | 12 | $5,201 | $433 |
| Phenytoin Sodium Extended | 146 | $4,156 | $28 |
| Divalproex | 78 | $3,843 | $49 |
| Donepezil | 166 | $3,587 | $22 |
| Fentanyl | 20 | $3,179 | $159 |
| Quetiapine | 53 | $3,071 | $58 |
| Clopidogrel | 97 | $3,064 | $32 |
| Carbidopa-Levodopa Er | 88 | $3,037 | $35 |
| Oxcarbazepine | 47 | $2,083 | $44 |
| Hydrocodone-Acetaminophen | 78 | $2,027 | $26 |
| Topiramate | 50 | $1,664 | $33 |
| Ropinirole | 29 | $1,512 | $52 |
| Desipramine | 14 | $1,447 | $103 |
| Carbamazepine | 90 | $1,328 | $15 |
| Carbamazepine Er | 17 | $1,037 | $61 |
| Primidone | 26 | $1,010 | $39 |
| Phenobarbital | 43 | $986 | $23 |
| Valproic Acid | 12 | $875 | $73 |
| Valproic Acid | 12 | $782 | $65 |
| Propranolol | 15 | $759 | $51 |
| Tramadol | 51 | $750 | $15 |
| Nortriptyline | 70 | $654 | $9 |
| Fluoxetine | 33 | $581 | $18 |
| Mirtazapine | 25 | $580 | $23 |
| Trihexyphenidyl | 80 | $572 | $7 |
| Baclofen | 28 | $334 | $12 |
| Lorazepam | 50 | $329 | $7 |
| Olanzapine | 23 | $321 | $14 |
| Clonazepam | 49 | $247 | $5 |
| Atorvastatin | 13 | $227 | $17 |
| Sumatriptan | 11 | $153 | $14 |
| Prednisone | 22 | $111 | $5 |
| Zolpidem | 25 | $110 | $4 |
| Amitriptyline | 13 | $44 | $3 |
Money from drug and device companies
$37 in 2023
| 2023 | 1 | 1 | None | $37 |
| 2020 | 1 | 1 | None | $17 |
| 2019 | 2 | 17 | None | $936 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mallinckrodt Hospital Products | Acthar | $37 | 1 payment
|
See the published payment
| Mallinckrodt Hospital Products | Meals · 2023-04-07 | Acthar | $37 |
See earlier years (2020, 2019)
2020: $17
| LivaNova USA | Vns Therapy | $17 | 1 payment
|
2019: $936
| LivaNova USA | Vns Therapy | $922 | 16 payments
|
| Supernus Pharmaceuticals | Oxtellar Xr | $14 | 1 payment
|
Checkups this office reported
13 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 95.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 36%That's less than half. | 821 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 36%That's less than half. | 592 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 63%That's more than half. | 48 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 0% | 32 |
| Dementia: Cognitive AssessmentAs Medicare defines this measure | 73% | 142 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 100%That's most of the people this applied to. Worse on this measure. | 57 |
| Medications listed in the chartVisits where the current medication list was documented | 87%That's most of the people this applied to. | 2,076 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 66%That's more than half. | 433 |
See the other 5 measures
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 99%That's most of the people this applied to. | 396 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 2%That's few of the people this applied to. Better on this measure. | 706 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 30% | 1,799 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 88%That's most of the people this applied to. | 242 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 40%That's less than half. | 896 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- ONC-ACB Surveillance Attestation
- Reports to a public-health or clinical registry
- Uses standard treatment protocols
- Exempt from electronic case reporting
- Exempt from immunization registry reporting
Professional record
- NPI
- 1912954298
- Licence
- CA A50500California A50500: Current · expires 2027-05-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A505000
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 1800 Sullivan Ave, Suite 508, Daly City, CA, 94015
- NPI first listed
- 2006-05-30
- NPI last updated
- 2007-08-07
This is when the NPI record was last certified, not a medical board exam.